# Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tucidinostat-plus-exemestane-for-postmenopausal-patients-with-advanced-hormone/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zefei Jiang,Wei Li,Xichun Hu,Qingyuan Zhang,Tao Sun,Shude Cui,Shusen Wang,Quchang Ouyang,Yongmei Yin,Cuizhi Geng,Zhongsheng Tong,Ying Cheng,Yueyin Pan,Yuping Sun,Hong Wang,Tao Ouyang,Kangsheng Gu,Jifeng Feng,Xiaojia Wang,Shubin Wang,Tianshu Liu,Jinghua Gao,Massimo Cristofanilli,Zhiqiang Ning,Xianping Lu |
| Citations | 271 |
| DOI | 10.1016/s1470-2045(19)30164-0 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2940712523 |
| PMID | 31036468 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Yueyin Pan](https://scholariq.org/researchers/yueyin-pan/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

## Paper topics

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Sirtuins and Resveratrol in Medicine](https://scholariq.org/topics/sirtuins-and-resveratrol-in-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.